Assistant Professor
Department of Otolaryngology-Head and Neck Surgery, LSU Health Shreveport, LA, USA
Shreveport, Louisiana, United States
Ameya Asarkar, MD, MHA, FACS is an Assistant Professor of Otolaryngology/Head and Neck Surgery at LSU Health Shreveport, Louisiana and Staff Physician (Otolaryngology) at the Overton Brooks Veterans Affairs Medical Center, Shreveport, Louisiana. He completed his medical school and residency in India and a Head and Neck and reconstructive surgery fellowship at Tata Memorial Hospital in Mumbai, India. He moved to the United States in 2016 to pursue an advanced Head and Neck Surgery fellowship at LSU Health, Shreveport. Upon completion of his fellowship, Dr Asarkar stayed on as faculty at LSU Health, Shreveport. His clinical focus includes the entire spectrum of head and neck surgery with specific interest in endocrine, and transoral robotic surgery.
Dr. Asarkar received the AAO-HNSF Bobby R. Alford Endowed CORE research grant in 2017 for his research investigating radiosensitizers in HPV positive PIK3 mutant head and neck Squamous cell carcinoma. His current research interests include clinical outcomes and cost effectiveness of treatment strategies in head and neck cancer patients. He has published several peer-reviewed papers and book chapters. He also serves as a reviewer on multiple national peer-reviewed journals. Dr Asarkar was inducted as a Fellow of the American College of Surgeons in 2020. Dr. Asarkar is actively involved with the American Head and Neck Society and serves on the salivary gland service committee, the clinical research and position statements committees. He is a member of numerous professional societies, including the American Academy of Otolaryngology Head and Neck Surgery, Federation of Head and Neck Oncology and Asia Pacific Society of Thyroid surgeons.
Primary Surgery vs Radiotherapy for Soft Palate Squamous Cell Carcinoma: A National Database Study
Saturday, September 28, 2024
10:00 AM – 10:06 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.